SEC Form 4 · accession 0001628280-26-042326
Vir Biotechnology, Inc. · VIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Coughlin
Director
Period of report
Jun 9, 2026
Accepted (ET)
Jun 10, 2026 · 6:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001706431
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 9, 2026 | A | 8,000 | $0.00 | A | 8,000 | D | |
| Common StockF3 | Jun 9, 2026 | A | 8,000 | $0.00 | A | 16,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $8.51 | Jun 9, 2026 | A | 16,000 | A | — | Jun 8, 2036 | Common Stock | 16,000 | 16,000 | D |
| Stock Option (Right to Buy)F5 | $8.51 | Jun 9, 2026 | A | 16,000 | A | — | Jun 8, 2036 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F21/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
- F3The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
- F41/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
- F5The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.